Alto Neuroscience, Inc. (ANRO)

18.36 +0.06 (+0.33%) USD  |  NYSE  |  Feb 24, 10:29
More

Alto Neuroscience EV to CFO

EV to CFO Chart

View EV to CFO for ANRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
Halozyme Therapeutics, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Fortress Biotech, Inc. Upgrade
Oramed Pharmaceuticals, Inc. Upgrade
Replimune Group, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade